1. Home
  2. MVIS vs SLGL Comparison

MVIS vs SLGL Comparison

Compare MVIS & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MicroVision Inc.

MVIS

MicroVision Inc.

HOLD

Current Price

$0.55

Market Cap

218.6M

Sector

Technology

ML Signal

HOLD

Logo Sol-Gel Technologies Ltd.

SLGL

Sol-Gel Technologies Ltd.

HOLD

Current Price

$71.50

Market Cap

247.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MVIS
SLGL
Founded
1993
1997
Country
United States
Israel
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
218.6M
247.1M
IPO Year
2010
2016

Fundamental Metrics

Financial Performance
Metric
MVIS
SLGL
Price
$0.55
$71.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$2.25
$110.00
AVG Volume (30 Days)
5.6M
16.0K
Earning Date
05-12-2026
05-22-2026
Dividend Yield
N/A
N/A
EPS Growth
23.91
N/A
EPS
N/A
N/A
Revenue
$664,000.00
N/A
Revenue This Year
$529.06
N/A
Revenue Next Year
$168.46
$223.84
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.51
$6.80
52 Week High
$1.73
$97.97

Technical Indicators

Market Signals
Indicator
MVIS
SLGL
Relative Strength Index (RSI) 39.58 48.36
Support Level $0.53 $67.47
Resistance Level $0.73 $81.66
Average True Range (ATR) 0.07 5.47
MACD -0.01 -0.11
Stochastic Oscillator 7.82 37.98

Price Performance

Historical Comparison
MVIS
SLGL

About MVIS MicroVision Inc.

Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars. Geographically, the company operates in United States, Germany, and Other foreign countries.

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

Share on Social Networks: